Canada· CA-DIN-02247651

TARO-TERCONAZOLE

A terconazole product containing terconazole, registered in Canada by TARO PHARMACEUTICALS INC. The same ATC class is registered in 3 of our 19 countries.

ATC G01AG02

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedTARO-TERCONAZOLEATCG01AG02REGISTER NO.CA-DIN-02247651PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Terconazole is registered in 3 of 19 countries.

Countries holding a registration under ATC G01AG02 (terconazole), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 2 of them publish a price we can compare per daily dose

Terconazole · ATC G01AG02

3 / 19 countries

  • Canada
  • Finlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of terconazole costs, country by country.

Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Terconazole · price per daily dose (80 mg)

USD · FX 28 Sept 2026

  • US United States$18.62 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
TERCONAZOLE
Manufacturer
TARO PHARMACEUTICALS INC
Country
Canada (CA)
ATC code
G01AG02
ATC class
Terconazole
Defined daily dose
80 mg, V
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Terconazole in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terconazole products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f848d9e7-9e83-4f26-85af-16af332a2a9d
GET /v1/drugs/f848d9e7-9e83-4f26-85af-16af332a2a9d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02247651",
  "form": "CREAM",
  "class": "Human",
  "routes": [
    "VAGINAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "G01AG02",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "71914",
  "strengths": [
    "0.4 %"
  ],
  "ahfs_class": null,
  "substances": [
    "TERCONAZOLE"
  ],
  "product_categorization": null
}

See everything about terconazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.